Key points from article :
YouthBio focuses on developing gene therapies aimed at epigenetic rejuvenation.
Particularly with the help of partial reprogramming by Yamanaka factors.
The company was founded in early 2021 by Yuri Deigin (CEO) and Viet Ly (CFO).
Dr. João Pedro de Magalhães will be the company's CSO.
Dr. Alejandro Ocampo will serve as lead research collaborator.
Previously, Mr. Deigin has led several early-stage pharmaceutical startups.
Deigin is optimistic that "...major breakthroughs that will enable us to add decades of healthy life to people."
Viet Ly is an angel investor and entrepreneur.
"Exploiting cellular reprogramming ... may result in a paradigm shift in medicine," said de Magalhães.
